StockStory.org on MSN
Clover Health (CLOV): Buy, sell, or hold post Q3 earnings?
Over the last six months, Clover Health’s shares have sunk to $2.60, producing a disappointing 13.5% loss - a stark contrast ...
Medicare Advantage (MA) insurer Clover Health is leaning on strong performance in the annual enrollment period and financial ...
Health insurance company Clover Health (NASDAQ:CLOV) announced in Q3 CY2025, with sales up 50.1% year on year to $496.7 million. Its GAAP loss of $0.05 per share was $0.02 below analysts’ consensus ...
Clover delivers market-leading Medicare Advantage growth, establishing a strong path to achieve its first-ever full year GAAP Net Income profitability in 2026. Disciplined, core-market growth, strong ...
WILMINGTON, Del., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today reported financial results for the fourth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results